Fluid metering device

Information

  • Patent Grant
  • 9995295
  • Patent Number
    9,995,295
  • Date Filed
    Wednesday, December 3, 2008
    16 years ago
  • Date Issued
    Tuesday, June 12, 2018
    6 years ago
Abstract
A device for metering fluids comprising a fluid chamber with one inlet or outlet port, at least one sidewall and a movable separator that is in contact with and separates the fluid in the chamber from the other components of the device, a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separator, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located at some point between actuator hydrating solution reservoir and the polymer actuator, effectively keeping actuator dry, and an external shell to hold all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chamber.
Description

The invention is a fluid metering device or pump that can deliver a pre-determined volume of fluid at a pre-determined pressure at a pre-determined rate of delivery. The device can be pre filled with the fluid during the manufacturing process or the device can be manufactured empty to be filled at a later time. The device can also meter multiple fluids in separate reservoirs at the same time and mix the fluids, if needed. The invention has particular utility as a device for metering drugs and will be described in connection with such utility, although other utilities are contemplated.


This invention also includes further modifications and improvements of US pending application 20040234401, now abandoned, PCT application US2004/005922, PCT application US05/045210 and PCT application US07/73188 which are herein included in this application in their entirety.


Controlled delivery of fluids, such as drugs, in the medical and veterinary fields is accomplished by a variety of methods. One method of controlled prolonged delivery of beneficial agents involves the use of osmotic delivery systems. These devices can be external devices or implanted to release beneficial agents in a controlled manner over a pre-selected time or administration period. In general, osmotic delivery systems operate by absorbing fluid from the outside environment and releasing corresponding amounts of the beneficial agent. These devices are somewhat limited in use and practicality due to inaccuracies or delays in the time it takes for the device to absorb a fluid and start expelling fluid flow out of the device. This delay is caused by air pockets or voids that remain and get compressed during the start of the pump process Delayed start-up of beneficial fluids delivery is a significant problem in osmotic delivery systems.


This problem is solved by using a flexible actuator material that can be compressed when pump is assembled, creating a preloaded pressure condition that negates any dead airspace compression issues, that can delay the time it takes to start expelling the beneficial fluids. Because the actuator is already under pressure it starts delivering fluids as soon as the fluids are released from any restrictions on the fluid tubing, as the material relaxes outwardly when released. This allows time for the actuator material to start absorbing the hydrating fluids.


Another problem with osmotic pumps is that osmotic pressure often is too low to deliver many of the new more viscous pharmaceutical agents and materials. Methods and materials are described that overcome the osmotic pressure issues with the introduction of protonated molecular repulsive forces, that occur upon hydration of the flexible actuator material and can produce pressures in excess 50 psi. easily delivering most fluids.


Another problem that is solved by a flexible actuator material is that the device can now be made itself of flexible materials as long as these materials are, less flexible, or stiffer than the actuator material, the more flexible a device is the more desirable it is for comfort of the patient, animal or package configuration.


The invention in broad aspect provides a device for metering fluids comprising a fluid chamber with one inlet or outlet port, at last one sidewall and a movable separator that is in contact with and separates the fluid in the chamber from the other components of the device. The device includes a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separator, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, and a fluid gate located at some point between actuator hydrating solution reservoir and the polymer actuator, effectively keeping the polymer actuator dry. An external shell holds all components on that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chamber.


In one aspect of the invention the fluid chamber is removable.


In another aspect of the invention the fluid chamber is made of a plastic, metal, glass, ceramic carbon or combination of these materials.


In another aspect of the invention the fluid chamber inlet/outlet port is capped or sealed by a pierce able septum.


In another aspect of the invention the movable separator is a rubber plunger.


In another aspect of the invention the movable separator is an elastomeric membrane and also a part of or attached to the fluid chamber.


In another aspect of the invention the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.


In another aspect of the invention the polymer actuator material is removable.


In another aspect of the invention the polymer actuator material is hydrophilic, or is a combination of hydrophilic and hydrophobic materials.


In another aspect of the invention the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.


In another aspect of the invention the fluid gate stopping actuator hydrating solution from contacting actuator is removable by the following methods of piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.


In another aspect of the invention the fluid gate is a membrane that can be torn, pierced or dissolved.


In another aspect of the invention the fluid gate can be opened and closed like a valve.


In another aspect of the invention the fluid in the fluid chamber is a medicine or has therapeutic value.


In another aspect of the invention the fluid camber can be filled in the device.


In another aspect of the invention the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.


In another aspect of the invention the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.


In another aspect of the invention the actuator material has varying layers of density and porosity.


In another aspect of the invention the actuator material has reacted and unreacted molecular sites.


In another aspect of the invention the actuator material has varying degrees of reacted and unreacted molecular sites.


In another aspect of the invention the actuator materials ratio of reacted to unreacted molecular sites determines the speed and pressure generation of the actuator material.


In another aspect of the invention protonation of reactive molecular sites within the actuator material, by interaction with the actuator hydrating solution or chemical byproduct of that interaction, determines the speed and pressure generation of the actuator material.


In another aspect of the invention the actuator materials density or porosity determines the speed and pressure generation of the actuator material.


In another aspect of the invention the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material.


In another aspect of the invention the actuator hydrating solution pH or chemical makeup determines the speed and pressure generation of the actuator material.


In another aspect of the invention, the device is implantable into a person, patient or animal.


In another aspect of the invention, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of fluids by the actuator material.


The invention also provides in an alternative a device for metering fluids comprising two or more separate fluid chambers with one inlet or outlet port, at least one sidewall and a movable separator that is in contact with and separates the fluid in the fluid chambers from the other components of the device. The device includes a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separators, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located between each actuator hydrating solution reservoir and the polymer actuator. An external shell holds all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chambers.


In one aspect of the alternative device one or more of the fluid chambers are removable.


In another aspect of the alternative device one or more of the fluid chambers are made of a plastic, metal, glass, ceramic carbon or combination of these materials.


In another aspect of the alternative device one or more of the fluid chambers inlet/outlet ports are capped or sealed by a pierce able septum.


In another aspect of the alternative device the movable separator is a rubber plunger.


In another aspect of the alternative device the movable separator is an elastomeric membrane and also a part of the fluid chamber.


In another aspect of the alternative device the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.


In another aspect of the alternative device the polymer actuator material is removable


In another aspect of the alternative device the polymer actuator material is hydrophilic, or is a combination of hydrophilic and hydrophobic materials.


In another aspect of the alternative device the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.


In another aspect of the alternative device the fluid gate stopping actuator hydrating solution from contacting actuator is removable or broken by the following methods piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.


In another aspect of the alternative device the fluid gate is a membrane that can be torn, pierced or dissolved.


In another aspect of the alternative device the fluid gate can be opened and closed like a valve.


In another aspect of the alternative device the fluids in the fluid chambers are a medicine or have therapeutic value.


In another aspect of the alternative device the fluid chambers can be filled in the device.


In another aspect of the alternative device the fluid chamber septums are pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.


In another aspect of the alternative device the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.


In another aspect of the alternative device the actuator material is an epoxy.


In another aspect of the alternative device the actuator material has varying layers of density and porosity.


In another aspect of the alternative device the actuator material has reacted and unreacted molecular sites.


In another aspect of the alternative device the actuator material has varying degrees of reacted and unreacted molecular sites.


In another aspect of the alternative device the actuator materials ratio of reacted to unreacted molecular sites determines the speed and pressure generation of the actuator material.


In another aspect of the alternative device the actuator materials density or porosity determines the speed and pressure generation of the actuator material.


In another aspect of the alternative device the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material


In another aspect of the alternative device the actuator hydrating solutions pH or chemical makeup determines the speed and pressure generation of the actuator material.


In another aspect of the alternative device there are one or more different actuator materials providing different speeds and pressures for one or more fluid chambers.


In yet another aspect of the alternative embodiment, the device is implantable into a person, patient or animal.


In the latter embodiment, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of body fluids by the actuator material.


In still yet another embodiment of the invention there is provided a device for metering fluids comprising two or more separate fluid chambers with one or more inlet or outlet ports that are in fluid connection with a mixing chamber, and have at least one sidewall and a movable separator that is in contact with and separates the fluid in the fluid chambers from the other components of the device. The device includes a mixing chamber with one or more inlet port openings that are in fluid contact with the fluid chambers, and an exit port opening, that is in fluid contact with tubing or fluid channel or method to transport mixed fluids to desired delivery site. A porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separators, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located between each actuator hydrating solution reservoir and the polymer actuator. An external shell holds all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chambers.


In the still yet another embodiment one or more of the fluid chambers are made of a plastic, metal, glass, ceramic carbon or combination of these materials.


In the still yet another embodiment one or more of the fluid chambers inlet/outlet ports are capped or sealed by a pierce able septum.


In the still yet another embodiment the movable separator is a rubber plunger.


In the still yet another embodiment the movable separator is an elastomeric membrane and also a part of the fluid chamber.


In the still yet another embodiment the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.


In the still yet another embodiment the polymer actuator material is removable


In the still yet another embodiment the polymer actuator material is hydrophilic or is a combination of hydrophilic and hydrophobic materials.


In the still yet another embodiment the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.


In the still yet another embodiment the fluid gate stopping actuator hydrating solution from contacting actuator is removable or broken by the following methods piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.


In the still yet another embodiment the fluid gate is a membrane that can be torn, pierced or dissolved.


In the still yet another embodiment the fluid gate can be opened and closed like a valve.


In the still yet another embodiment the fluids in the fluid chambers are a medicine or have therapeutic value.


In the still yet another embodiment the fluid cambers can be filled in the device.


In the still yet another embodiment the mixing chamber exit port is capped or sealed by a septum, septum is pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.


In the still yet another embodiment the mixing chamber exit port is capped or sealed by a septum, septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.


In the still yet another embodiment the actuator material is an epoxy.


In the still yet another embodiment the actuator material has varying layers of density and porosity.


In the still yet another embodiment the actuator material has reacted and un-reacted molecular sites.


In the still yet another embodiment the actuator material has varying degrees of reacted and un-reacted molecular sites.


In the still yet another embodiment the actuator materials ratio of reacted to un-reacted molecular sites determines the speed and pressure generation of the actuator material.


In the still yet another embodiment the actuator materials density or porosity determines the speed and pressure generation of the actuator material.


In the still yet another embodiment the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material


In the still yet another embodiment the actuator hydrating solutions pH or chemical makeup determines the speed and pressure generation of the actuator material.


In the still yet another embodiment there are one or more different actuator materials providing different speeds and pressures for one or more fluid chambers.


In yet another embodiment, the device is implantable into a person, patient or animal.


In the latter embodiment, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of body fluids by the actuator material.


In yet another embodiment of the invention a two part insulin is mixed together at the prescribed ratio and metered after mixing to a patient via subcutaneous delivery.


In still yet another embodiment of the invention multiple types of medication, gene therapies, proteins etc. are metered to a patient via the best route to deliver the particular medications at the desired site on or in the patient.





Further features and advantages of the present invention will be seen from the following detailed description, taken in conjunction with the accompanying drawings, wherein



FIG. 1 schematically illustrates a representative embodiment of the invention;



FIG. 2 is a side cross-sectional view of an embodiment of the invention, and FIG. 2A is a view similar to FIG. 2 of a second embodiment of the invention;



FIG. 3 shows a single actuator;



FIG. 4 shows a plurality of actuators; and



FIG. 5 illustrates another embodiment of the invention.





Referring to the drawings, the present invention in one aspect comprises a chamber made in two parts that are assembled together with one or more inlet or outlet ports or openings (7) having tubing (7A) extended therethrough that are in fluid or gaseous connection with a mixing chamber 30. The displacement of the volume in the chamber is accomplished by using one or more but not limited to, polymers, co polymers, block polymers, hydro gels or epoxy materials that are hydrophilic and used as actuator material (1). For ease of illustration, FIG. 1 and FIG. 2 are not drawn to scale. Also, the exterior shell wall is illustrated in phantom in one dimension. The actuator material reacts by degrees of swelling to the chemical composition of the solution (4) hydrating the actuator material. The actuator hydrating fluid can range in pH from 0-14, depending on the actuator material, degree of swelling, pressure and displacement time required for the desired performance of the invention. The actuator material hydrating solution is kept separate from the fluid or gas being pumped or displaced by a flexible or moveable membrane, elastomeric or plunger material (5) that can stretch, move or slide as the fluid or gas volume (6) in the chamber is displaced by the actuator expansion or contraction and continue to keep a fluid or gas seal between the actuator hydrating fluid and the fluid or gas being pumped. The fluid chamber inlet and/or outlet may be capped or sealed by a piercable septum as shown in phantom at 34 in FIG. 2. FIG. 2A is similar to FIG. 2, but comprises two separate walled chambers with one or more fluid inlet or fluid outlet ports that are in fluid connection with a mixing chamber, etc., as described for FIG. 2.


One part of the ph responsive metering device or pump has one or more polymer actuator materials housed within or on a porous media substrate (2) that is less flexible than the actuator material. The second part of the chamber is a hollow shell, cavity or cylinder (3) made from material that is also less flexible than the actuator material. These fluid chamber materials can be made of but not limited to plastics, elastomeric material, glass, ceramics, metals and combinations of these. These are then housed in an external shell (8) for the form factor. All of the materials are standard in the relevant industry the device is used in and the performance requirements of the fluid or gaseous metering device or pump and are well known to experts in each field of use.


In one preferred embodiment, a flexible patch for liquid drug delivery, all of the parts are assembled by lamination techniques well know in the plastics industry, such as but not limited to glue, heat, pressure, UV irradiation, RF, or sonic welding. In the case of a cylinder or tube a. movable but fluid sealing plunger or piston (18) may be used. An example of this is a pre-filled medication vial or syringe such as but not limited to, the 3 ml glass vials or syringes used for insulin with an exit port covered by, capped or sealed by a septum shown at (20) at the chamber outlet end and rubber stopper that is pushed to dispense the fluid at the opposite end, which is open. The moveable rubber plunger or stopper keeps a sterile fluid seal but can be pushed to displace or dispense the medication once the septum is pierced and the medication is in fluid connection with a tube or needle that is able to inject medication into the patient. In both examples the fluid being metered or pumped is separate from the fluid used to hydrate the actuation material. The porous media is a ridged or semi ridged substrate or housing for the actuator material, it is also a fluid conduit to hydrate the actuator material. The porous material can be molded, extruded or stamped to allow geometric flexibility of the con figuration that makes up the complete device.


For example a medical device that uses industry standard medication vials such as but not limited to the 3 ml glass insulin vials or syringes, is typically referred to as an insulin syringe pump. These pumps are electronically controlled and driven by electric motors that turn very precise screw mechanisms in increments to push the syringe stopper and deliver small incremental doses of the insulin over a pre programmed time and rate.


The ph responsive pump uses the migration of the desired ph chemical solution through the polymer matrix and the resulting expansion or contraction as the mechanism to push the syringe stopper. As the polymer matrix expands or contracts it produces continuous pressure thereby offering continuous delivery rates. The speed of this reaction can be increased or decreased several ways.


By increasing the porosity of the polymer the speed increases or by decreasing the porosity of the polymer the actuation speed is decreased. The actuator material porosity can be adjusted by changing ratios of materials, adding catalysts or other materials that can be washed out with a solvent after the polymerization process, many methods are used dependent on the materials being used to make the actuator material and are well known within the polymer industry.


By increasing available external surface area of the actuator material the speed increases, the reverse is also true if you decrease available surface area, one way this is accomplished by stacking or assembling actuators together. For example a bundle of round strands (28) of actuator material provides a large amount of external surface area for rapid fluid migration, yet still provides good pushing force as it expands. Another actuator configuration to increase surface area is a hollow tube (9), as the actuator expands it is omni-directional and the center of a tube of the material allows a conduit for rapid uptake of fluid until it closes from the expansion.


In another preferred actuator or device configuration a fluid wicking material (10) that can be ridged, flexible or elastomeric is used. The wicking material adds a uniform fluid conduit or channel internally, through, along, in between or externally around the actuator material. The wicking material can be a hydrophobic or hydrophilic material that is compatible to the chemical fluid hydrating the actuator material. By inserting a wicking material either into or around the porous actuator material (not shown for the sake of simplifying the drawings) it provides a uniform hydration method that provides continuous pressure at the desired speed of expansion or contraction which results in a linear rate of fluid or gas displacement from the pump chamber. This solves the problem of increasing or decreasing pump or metering rate curves that develop as the actuator material expands or contracts and ratio of actuator surface area or exposed footprint to the actuator hydration fluid changes.


Yet another preferred actuation material configuration is a foamed actuator material this allows fast uptake of fluids, like a sponge, which results in faster actuation cycles or times. The increased surface area can also increases reaction surface area of the material, for example by incorporating primary, secondary or combinations of amines or other functional molecular groups in a polymer or actuator material, results in enhanced performance characteristics as the amines react to the ph of the hydrating solution in conjunction with the hydration effects of the actuator material.


The foaming can be accomplished by but not limited to the use of catalysts, emulsifiers, foaming agents, colloidal suspensions, heating, peroxides even whipping air into the liquid materials during polymerization can produce foamed actuation material. Oxidizing materials incorporated to add desired performance characteristics to the actuator materials can also result in foaming, these techniques are well known in the chemical and polymer industry.


Another preferred actuator material configuration is graduated porosity of the material. This actuator material can be made in one piece or by stacking layers of materials of different porosities and compositions together. One way of producing a one piece material is by adding layers of different porosity liquid actuator material into a mold, while still liquid each layer will mix slightly with the layer already in the mold and then the material can be polymerized or cured to produce the actuator material. Another way to produce the graduated porosity material is to pour each layer one at a time in the same mold, polymerize or cure it, then add the next liquid material layer and polymerize or cure it and continue adding layers until finished.


In another preferred embodiment the actuator material is kept dry and attached to the porous material or housed in it. The actuator hydrating solution is stored or kept separate from the actuator material by a thin film that is burst, pierced or dissolved when the device is started. The fluid is absorbed by or flows through the porous material and starts hydrating the actuator material starting the pumping or dispensing action. The embodiment also envisions having dissolving or time release capsules that can change the ph of the solution over time as the dissolve in the actuator hydrating solution, for example polymer actuators that have amines incorporated turn the hydrating solution to a basic ph of 9 or 10 over time, a slowly dissolving acidic chemical would extend and get the maximum time and pressure needed by the device because the amines react to the degree of the acid in the solution, these are all ways to control or engineer the performance of the device for a specific application.


Multiple actuators are another embodiment of the devices. The actuators are positioned in line or sequence. Sealed sections hold the actuator material and keep the actuator hydrating solution from each of the next in line or sequenced actuators. The pressure generated over time by the actuator material is used to open the next seal via puncture, bursting or physically opening a valve to allow fluid into the next section and to the actuator material and a progression of the actuators and actuator fluid can be controlled this way to engineer the performance of the devices for applications.


Preferred embodiments of the complete devices include a disposable one time liquid drug delivery patch that can be flexible and use disease, industry or manufacturers specific delivery routes or skin barrier technology to delivery the liquid drug through the patients skin and into the patient, for example a subcutaneous injection or infusion via needle and tubing another method is micro needle array, yet another is ionophoresis.


Another device embodiment is a one use cartridge that dispenses an industry or manufacturer's specific pre loaded liquid drug container and uses disease, industry or manufacturer's specific delivery routes to the patient, for example Insulin for diabetes can be delivered via a subcutaneous injection or infusion via needle and tubing in fluid connection to the drug container. By using a preloaded 3 ml vial of insulin the device can deliver a continuous pre determined rate of insulin to the patient, this is accomplished by the expansion characteristics of the actuator material that is used in the device to displace the insulin in the preloaded insulin vial.


Other device embodiments can also deliver bolus doses to the patient by have a predetermined bolus dose volume chamber in fluid connection with the delivery route and incorporating one way valves. A flexible membrane or covering that will deflect back to original shape once pressed is attached to one side or part of the bolus dose chamber and is physically pressed by the patient to dispense the bolus volume when needed. The one way valves allow the fluid to only travel in only one direction, towards the patient, to empty the bolus chamber and then the negative pressure in the dispensed chamber draws more fluid in from the fluid container over a predetermined time to refill bolus chamber for next bolus dose. Patient administered bolus doses are needed in many therapeutic protocols, pain and diabetes are examples of this need.


Other devices are envisioned that can use multiple liquid drug containers at the same time and mix the liquids prior to delivery or deliver separate liquids at different rates and pressures to the patient either directly as described above, or indirectly such as dispensing into an IV line or bag that will be or is attached to the patient and is delivering larger volumes of liquid drugs, hydrating or nutritional fluids. Chemotherapy, 2 part insulin, and antibiotics are all therapies that need this ability.


There are also many non medical uses for these devices such as pumping, mixing or dispensing chemicals over an extended period of time at predetermined rates. Mixing and dispensing 2 and 3 part epoxies at predetermined rates etc. The use of metering of gasses and gaseous flows can also be accomplished and is envisioned by the described inventions. The ability to engineer a device that produces a predetermined pressure at a predetermined rate over a predetermined time is very advantageous as many chemicals, glues, epoxies etc. are different viscosities so require the ability to be pumped or delivered at different pressures and rates.


The described inventions and components allow fluids and gaseous materials to be metered, pumped or dispensed in a low cost yet very accurate manner over extended time frames and pressures if needed. Multiple forms of the invention are described and are not meant to limit the scope of the inventions in any manner, shape, form factor or use.


The specific embodiments disclosed and illustrated herein should not be considered as limiting the scope of the invention, as understood by a person having ordinary skill in the art. Numerous variations are possible without falling outside the scope of the appended claims. The subject matter of the invention includes all novel and nonobvious combinations and subcombinations of the various elements, features, functions, and/or properties disclosed herein.

Claims
  • 1. A device for metering a fluid comprising a walled fluid chamber with at least one fluid inlet or fluid outlet port, at least one chamber wall and a movable separator that is in contact with and retains the fluid in the chamber, a porous media substrate and a wicking material, an actuator formed of a flexible polymer material in contact with the porous media substrate and with the moveable separator, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between the actuator hydrating solution reservoir and the polymer actuator, effectively keeping the actuator dry, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from the fluid chamber, wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
  • 2. The device in claim 1 wherein the actuator hydrating solution has a pH or chemical makeup that effects a speed and pressure generation of the actuator material.
  • 3. The device in claim 2, wherein the device is adapted to be implanted in a person or animal and utilizes body fluids as the actuator hydrating solution and the said hydrating inlet port in the exterior shell allows the uptake of fluids by the actuator material.
  • 4. The device as claimed in claim 1, wherein the fluid chamber and/or the actuator is removable.
  • 5. The device as claimed in claim 1, wherein the fluid chamber and/or the porous actuator housing is made of a material selected from the group consisting of a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
  • 6. The device as claimed in claim 1, wherein the fluid chamber inlet and/or outlet port is capped or sealed by a pierceable septum.
  • 7. The device as claimed in claim 1, wherein the movable separator is a rubber plunger.
  • 8. The device as claimed in claim 1, wherein the movable separator is an elastomeric membrane and also a part of or attached to the fluid chamber.
  • 9. The device as claimed in claim 1, wherein the actuator is formed of a hydrophilic polymer material or a combination of a hydrophilic material and an hydrophobic polymer material.
  • 10. The device as claimed in claim 1, wherein the actuator, fluid gate, porous media substrate, and actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with the actuator, and said hydrating solution inlet port is covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
  • 11. The device as claimed in claim 1, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the gate out of the actuator hydrating solution to allow hydration of the actuator material.
  • 12. The device as claimed in claim 1, wherein the fluid gate is a membrane.
  • 13. The device as claimed in claim 1, wherein the fluid in the fluid chamber is a medicine or has therapeutic value.
  • 14. The device as claimed in claim 1, wherein the fluid gate is adapted to be pierced and fluid released into tubing adapted for contact with a person or animal.
  • 15. The device as claimed in claim 1, wherein the actuator hydrating solution has a ratio of reacted to unreacted molecular sites that effects a speed and pressure generation of the actuator.
  • 16. The device as claimed in claim 1, wherein protonation of reactive molecular sites within the actuator material, by interaction with the actuator hydrating solution or chemical byproduct of that interaction, effects a speed and pressure generation of the actuator.
  • 17. The device as claimed in claim 1, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator.
  • 18. The device as claimed in claim 1, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the porous a wicking material effects a speed and pressure generation of the actuator.
  • 19. The device as claimed in claim 1, wherein the device is adapted to be implanted into a person or animal.
  • 20. A device for metering fluids comprising two or more separate fluid chambers with at least one fluid inlet or fluid outlet port, at least one chamber wall and a movable separator that is in contact with and retains the fluid in the fluid chambers, a porous media substrate and wicking material, an actuator formed of a flexible polymer material in contact with the porous media substrate and with the movable separators, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between each actuator hydrating solution reservoir, and the actuator, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chambers, thereby dispensing fluid from the fluid chambers, wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
  • 21. The device as claimed in claim 20, wherein the actuator hydrating solution pH or chemical makeup effects a speed and pressure generation of the actuator material.
  • 22. The device as claimed in claim 21, wherein the device is adapted to be implanted into a person or animal, and utilizes body fluids as the actuator hydrating solution and the said hydrating inlet port in the exterior shell allows the uptake of body fluids by the actuator material.
  • 23. The device as claimed in claim 20, wherein multiple types of medication, gene therapies or proteins are metered to a patient at a desired site on or in the patient.
  • 24. The device as claimed in claim 20, wherein one or more of the fluid chambers and/or the porous actuator housing are made of a material selected from the group consisting of a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
  • 25. The device as claimed in claim 20, wherein one or more of the fluid chambers inlet and/or outlet ports are capped or sealed by a pierceable septum.
  • 26. The device as claimed in claim 20, wherein the movable separator is a rubber plunger.
  • 27. The device as claimed in claim 20, wherein the movable separator is an elastomeric membrane and also a part of the fluid chamber.
  • 28. The device as claimed in claim 20, wherein the actuator is formed of a hydrophilic polymer material or a combination of a hydrophilic and hydrophobic material.
  • 29. The device as claimed in claim 20, wherein the actuator, fluid gate, the porous media substrate, and the actuator hydrating solution reservoir are enclosed together as a sealed unit with said movable separator in contact with the actuator with a port covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
  • 30. The device as claimed in claim 20, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the gate out of way of the actuator hydrating solution to allow hydration of the actuator material.
  • 31. The device as claimed in claim 20, wherein the fluid gate is a membrane.
  • 32. The device as claimed in claim 20, wherein the fluids in the fluid chambers are a medicine or have a therapeutic value.
  • 33. The device as claimed in claim 20, wherein the fluid gate is adapted to be pierced and fluid released into tubing that is in contact with a person or animal.
  • 34. The device as claimed in claim 20, wherein the actuator is formed of an epoxy material.
  • 35. The device as claimed in claim 20, wherein the actuator hydrating solution has a ratio of reacted to unreacted molecular sites that effects a speed and pressure generation of the actuator.
  • 36. The device as claimed in claim 20, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator.
  • 37. The device as claimed in claim 20, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the wicking material effects a speed and pressure generation of the actuator.
  • 38. The device as claimed in claim 20, wherein the actuator comprises a bundle of two or more actuators formed of different materials providing different speeds and pressures for the fluid chambers.
  • 39. The device as claimed in claim 20, wherein the device is adapted to be implanted into a person or animal.
  • 40. A device for metering fluids comprising two or more separate fluid walled chambers with one or more fluid inlet or fluid outlet ports that are in fluid connection with a mixing chamber, and have at least one chamber wall and a movable separator that is in contact with and retains the fluid in the fluid chambers, said outlet port being in fluid contact with tubing or fluid channel to transport mixed fluids to a desired delivery site; a porous media substrate and wicking material, an actuator formed of a flexible polymer material in contact with a porous media substrate and with the moveable separators, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between each actuator hydrating solution reservoir and the actuator, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from the fluid chambers wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
  • 41. The device as claimed in claim 40, wherein the actuator hydrating solution pH or chemical makeup effects a speed and pressure generation of the actuator material.
  • 42. The device as claimed in claim 41, wherein the device is adapted to be implanted in the body of a person or animal, and utilizes body fluids as the actuator hydrating solution and said hydrating inlet port in the exterior shell that allows an uptake of body fluids by the actuator material.
  • 43. The device as claimed in claim 40, wherein multiple types of medication, gene therapies or proteins are metered to a patient at a desired site on or in the patient.
  • 44. The device as claimed in claim 40, wherein one or more of the fluid chambers and/or the porous media substrate are made of a material selected from a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
  • 45. The device as claimed in claim 40, wherein one or more of the fluid chambers inlet and/or outlet ports are capped or sealed by a pierceable septum.
  • 46. The device as claimed in claim 40, wherein the movable separator is a rubber plunger.
  • 47. The device as claimed in claim 40, wherein the movable separator is an elastomeric membrane and also a part of the fluid chamber.
  • 48. The device as claimed in claim 40, wherein the polymer actuator is formed of an hydrophilic material or a combination of an hydrophilic and an hydrophobic material.
  • 49. The device as claimed in claim 40, wherein the actuator, fluid gate, the porous media substrate, and the actuator hydrating solution reservoir are enclosed together as a sealed unit with the movable separator in contact the with actuator, with the hydration solution inlet port covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
  • 50. The device as claimed in claim 40, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the fluid gate out of the actuator hydrating solution path to allow hydration of the actuator material.
  • 51. The device as claimed in claim 40, wherein the fluid gate is a membrane.
  • 52. The device as claimed in claim 40, wherein the fluids in the fluid chambers are a medicine or have therapeutic value.
  • 53. The device as claimed in claim 40, wherein the fluid inlet or outlet port is capped or sealed by a septum adapted to be pierced and fluid released into tubing adapted for contact with a person or animal.
  • 54. The device as claimed in claim 40, wherein the actuator is formed of an epoxy material.
  • 55. The device as claimed in claim 40, wherein the actuator hydrating solution has a ratio of reacted to un-reacted molecular sites that effects a speed and pressure generation of the actuator material.
  • 56. The device as claimed in claim 40, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator material.
  • 57. The device as claimed in claim 40, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material effects a speed and pressure generation of the actuator.
  • 58. The device as claimed in claim 40, wherein there are two or more different actuator materials which effect speeds and pressures for the fluid chambers.
  • 59. The device as claimed in claim 40, wherein the device is adapted to be implanted into a person or animal.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority from PCT Patent Application Serial No. PCT/US08/85421 filed Dec. 3, 2008, which claims priority from U.S. Provisional Application Ser. No. 60/992,003, filed Dec. 3, 2007, the contents of which are incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2008/085421 12/3/2008 WO 00 6/2/2010
Publishing Document Publishing Date Country Kind
WO2009/073734 6/11/2009 WO A
US Referenced Citations (311)
Number Name Date Kind
3029743 Johns Apr 1962 A
3922328 Johnson Nov 1975 A
4034380 Isayama Jul 1977 A
4111202 Theeuwes Sep 1978 A
4190411 Fujimoto Feb 1980 A
4203440 Theeuwes May 1980 A
4299220 Dorman Nov 1981 A
4327725 Cortese et al. May 1982 A
4395719 Majewski et al. Jul 1983 A
4423166 Moriarty et al. Dec 1983 A
4432699 Beckman et al. Feb 1984 A
4449893 Beckman May 1984 A
4449983 Cortese et al. May 1984 A
4507363 Chow et al. Mar 1985 A
4538607 Saul Sep 1985 A
4551139 Plaas et al. Nov 1985 A
4559038 Berg et al. Dec 1985 A
4595583 Eckenhoff et al. Jun 1986 A
4624847 Ayer et al. Nov 1986 A
4624848 Lee Nov 1986 A
4650469 Berg et al. Mar 1987 A
4655767 Woodard et al. Apr 1987 A
4663149 Eckenhoff et al. May 1987 A
4675174 Eckenhoff Jun 1987 A
4723958 Pope et al. Feb 1988 A
4772474 Eckenhoff et al. Sep 1988 A
4781714 Eckenhoff et al. Nov 1988 A
4808084 Tsubouchi et al. Feb 1989 A
4810535 McCollum et al. Mar 1989 A
4842493 Nilsson Jun 1989 A
4863456 Stephens et al. Sep 1989 A
4948592 Ayer et al. Aug 1990 A
4963141 Eckenhoff Oct 1990 A
5000957 Eckenhoff et al. Mar 1991 A
5034229 Magruder et al. Jul 1991 A
5037420 Magruder et al. Aug 1991 A
5059423 Magruder et al. Oct 1991 A
5061242 Sampson Oct 1991 A
5070560 Wilkinson Dec 1991 A
5100933 Tanaka et al. Mar 1992 A
5105983 Sancoff et al. Apr 1992 A
5110596 Magruder et al. May 1992 A
5175246 Smith Dec 1992 A
5192197 Culp Mar 1993 A
5232702 Pfister et al. Aug 1993 A
5246705 Venkatraman et al. Sep 1993 A
5275853 Silvis Jan 1994 A
5279544 Gross et al. Jan 1994 A
5279565 Klein et al. Jan 1994 A
5284133 Burns et al. Feb 1994 A
5300299 Sweet et al. Apr 1994 A
5304121 Sahatjian Apr 1994 A
5327041 Culp Jul 1994 A
5328696 Noel Jul 1994 A
5336057 Fukuda et al. Aug 1994 A
5348746 Dong et al. Sep 1994 A
5354264 Bae et al. Oct 1994 A
5376378 Li et al. Dec 1994 A
5380760 Wendel et al. Jan 1995 A
5412821 Wilkinson May 1995 A
5429585 Liang Jul 1995 A
5431921 Thombre Jul 1995 A
5474783 Miranda et al. Dec 1995 A
5498255 Wong Mar 1996 A
5520643 Ensminger et al. May 1996 A
5546932 Galli Aug 1996 A
5573668 Grosh et al. Nov 1996 A
5587237 Korpman et al. Dec 1996 A
RE35474 Woodard et al. Mar 1997 E
5618899 Appelt et al. Apr 1997 A
5622482 Lee Apr 1997 A
5630709 Bar-Cohen May 1997 A
5633009 Kenealy et al. May 1997 A
5645855 Lorenz Jul 1997 A
5656286 Miranda et al. Aug 1997 A
5674192 Sahatjian et al. Oct 1997 A
5687748 Conrad et al. Nov 1997 A
5692256 Kramer et al. Dec 1997 A
5714160 Magruder et al. Feb 1998 A
5718700 Edgren et al. Feb 1998 A
5779668 Grabenkort Jul 1998 A
5798600 Sager et al. Aug 1998 A
5810001 Genga et al. Sep 1998 A
5823178 Lloyd et al. Oct 1998 A
5891463 Bello et al. Apr 1999 A
5916968 Hariharan et al. Jun 1999 A
5939477 Pretzer et al. Aug 1999 A
5951999 Therriault et al. Sep 1999 A
5954706 Sahatjian Sep 1999 A
5955549 Chang Sep 1999 A
5961298 Bar-Cohen et al. Oct 1999 A
5979892 Smith Nov 1999 A
5997501 Gross et al. Dec 1999 A
6004115 da Costa Dec 1999 A
6010485 Buch-Rasmussen et al. Jan 2000 A
6024976 Miranda et al. Feb 2000 A
6066325 Wallace et al. May 2000 A
RE36754 Noel Jun 2000 E
6074178 Bishop et al. Jun 2000 A
6074179 Jokela et al. Jun 2000 A
6106245 Cabuz Aug 2000 A
6109852 Shahinpoor et al. Aug 2000 A
6143138 Becker Nov 2000 A
6152898 Olsen Nov 2000 A
6157113 Hunter et al. Dec 2000 A
6165155 Jacobsen et al. Dec 2000 A
6174546 Therriault et al. Jan 2001 B1
6180133 Quan et al. Jan 2001 B1
6183434 Eppstein Feb 2001 B1
6184608 Cabuz et al. Feb 2001 B1
6193996 Effing et al. Feb 2001 B1
6206850 O'Neil Mar 2001 B1
6210712 Edgren et al. Apr 2001 B1
6213739 Phallen et al. Apr 2001 B1
6221383 Miranda et al. Apr 2001 B1
6223369 Maier et al. May 2001 B1
6249076 Madden et al. Jun 2001 B1
6277401 Bello et al. Aug 2001 B1
6312715 Cantor et al. Nov 2001 B1
6316022 Mantelle et al. Nov 2001 B1
6319245 Berrigan Nov 2001 B1
6336907 Dono et al. Jan 2002 B1
6337086 Kanios et al. Jan 2002 B1
6352715 Hwang et al. Mar 2002 B1
6365178 Venkateshwaran et al. Apr 2002 B1
6365185 Ritschel et al. Apr 2002 B1
6368318 Visuri et al. Apr 2002 B1
6378292 Youngner Apr 2002 B1
6387077 Klibanov et al. May 2002 B1
6392777 Elliott et al. May 2002 B1
6409716 Sahatjian et al. Jun 2002 B1
6450773 Upton Sep 2002 B1
6461644 Jackson et al. Oct 2002 B1
6464476 Ross et al. Oct 2002 B2
6471686 Berrigan Oct 2002 B1
6475639 Shahinpoor et al. Nov 2002 B2
6490483 Willis Dec 2002 B2
6531152 Lerner et al. Mar 2003 B1
6537194 Winkler Mar 2003 B1
6578245 Chatterjee et al. Jun 2003 B1
6586512 Dukes Jul 2003 B1
6632522 Hyde et al. Oct 2003 B1
6664718 Pelrine et al. Dec 2003 B2
6682318 Takeuchi et al. Jan 2004 B2
6682500 Soltanpour Jan 2004 B2
6685442 Chinn et al. Feb 2004 B2
6726678 Nelson Apr 2004 B1
6766817 da Silva Jul 2004 B2
6791003 Choi et al. Sep 2004 B1
6796970 Klitmose et al. Sep 2004 B1
6809462 Pelrine et al. Oct 2004 B2
6864295 Mitarai Mar 2005 B2
6869275 Dante et al. Mar 2005 B2
6876135 Pelrine et al. Apr 2005 B2
6902704 Wilson Jun 2005 B2
6940211 Pelrine et al. Sep 2005 B2
6948636 Fischer et al. Sep 2005 B1
6949079 Westberg et al. Sep 2005 B1
6955923 Hartting Oct 2005 B2
6960864 Urano et al. Nov 2005 B2
7285255 Kadlec et al. Oct 2007 B2
7411792 Richards et al. Aug 2008 B2
7453187 Richards et al. Nov 2008 B2
7458956 Adams Dec 2008 B1
7544260 Banister et al. Jun 2009 B2
7553903 Riegel et al. Jun 2009 B2
7700129 Ito et al. Apr 2010 B2
7820427 Unger et al. Oct 2010 B2
8190270 Wingeier et al. May 2012 B2
20010053383 Miranda et al. Dec 2001 A1
20020001571 Wu Jan 2002 A1
20020004064 Quan et al. Jan 2002 A1
20020007014 Hyde et al. Jan 2002 A1
20020010412 Eppstein Jan 2002 A1
20020015733 Flashner-Barak et al. Feb 2002 A1
20020043895 Richards et al. Apr 2002 A1
20020106402 Hartwig Aug 2002 A1
20020115740 Beuhler et al. Aug 2002 A1
20020128572 Chang Sep 2002 A1
20020128618 Frenz et al. Sep 2002 A1
20020147208 Fleshner-Barak et al. Oct 2002 A1
20020156463 Berrigan Oct 2002 A1
20020173745 Santini et al. Nov 2002 A1
20020183738 Chee et al. Dec 2002 A1
20020193754 Cho Dec 2002 A1
20030014036 Varner et al. Jan 2003 A1
20030051292 Ferrand et al. Mar 2003 A1
20030054025 Cantor et al. Mar 2003 A1
20030065303 Wellman et al. Apr 2003 A1
20030069359 Torii et al. Apr 2003 A1
20030072792 Flanigan et al. Apr 2003 A1
20030108590 Peery et al. Jun 2003 A1
20030124189 Zentner et al. Jul 2003 A1
20030135158 Gonnelli Jul 2003 A1
20030139495 Zentner et al. Jul 2003 A1
20030143257 Fleshner-Barak et al. Jul 2003 A1
20030152616 Hartwig Aug 2003 A1
20030153900 Aceti et al. Aug 2003 A1
20030156953 Chinn et al. Aug 2003 A1
20030163099 Wermeling et al. Aug 2003 A1
20030216683 Shekalim Nov 2003 A1
20030232198 Lamberti et al. Dec 2003 A1
20040030262 Fisher et al. Feb 2004 A1
20040068224 Couvillon et al. Apr 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040102762 Gilbert May 2004 A1
20040106893 Hunter Jun 2004 A1
20040106894 Hunter Jun 2004 A1
20040112442 Maerkl et al. Jun 2004 A1
20040133159 Haider et al. Jul 2004 A1
20040138603 Cleary et al. Jul 2004 A1
20040142023 Hartwig Jul 2004 A1
20040149288 Koch Aug 2004 A1
20040176502 Raymond et al. Sep 2004 A1
20040176748 Abramson et al. Sep 2004 A1
20040186419 Cho Sep 2004 A1
20040202708 Roehrig et al. Oct 2004 A1
20040204677 Wellman et al. Oct 2004 A1
20040219194 Finckh et al. Nov 2004 A1
20040220548 Heruth et al. Nov 2004 A1
20040234401 Banister Nov 2004 A1
20040242709 Oguro et al. Dec 2004 A1
20040265545 McKean et al. Dec 2004 A1
20050033230 Alchas et al. Feb 2005 A1
20050043657 Couvillon Feb 2005 A1
20050058695 Anigbogu et al. Mar 2005 A1
20050137577 Heruth et al. Jun 2005 A1
20050137578 Heruth et al. Jun 2005 A1
20050137579 Heruth et al. Jun 2005 A1
20050261631 Clarke et al. Nov 2005 A1
20050273081 Olsen Dec 2005 A1
20050273082 Olsen Dec 2005 A1
20050287214 Ayer et al. Dec 2005 A1
20060021614 Wermeling et al. Feb 2006 A1
20060076540 Zama et al. Apr 2006 A1
20060078603 Nguyen Apr 2006 A1
20060078604 Kanios et al. Apr 2006 A1
20060084942 Kim et al. Apr 2006 A1
20060089619 Ginggen Apr 2006 A1
20060094985 Aceti et al. May 2006 A1
20060094989 Scott et al. May 2006 A1
20060110596 Palasz et al. May 2006 A1
20060135911 Mittur Jun 2006 A1
20060142478 Luo Jun 2006 A1
20060142875 Keyes et al. Jun 2006 A1
20060146475 Zhong et al. Jul 2006 A1
20060183216 Handique et al. Aug 2006 A1
20060188558 Jackson et al. Aug 2006 A1
20060195057 Kriesel et al. Aug 2006 A1
20060200083 Freyman et al. Sep 2006 A1
20060204532 John Sep 2006 A1
20060213674 Dierker, Jr. et al. Sep 2006 A1
20060276744 Falk Dec 2006 A1
20070021697 Ginther et al. Jan 2007 A1
20070031495 Eppstein et al. Feb 2007 A1
20070052139 Gilbert Mar 2007 A1
20070078376 Smith Apr 2007 A1
20070082038 Gale et al. Apr 2007 A1
20070088267 Shekalim Apr 2007 A1
20070092570 Missel et al. Apr 2007 A1
20070098771 Audett et al. May 2007 A1
20070098772 Westcott et al. May 2007 A1
20070100355 Bonde et al. May 2007 A1
20070104771 Audett et al. May 2007 A1
20070134310 Nedberge et al. Jun 2007 A1
20070148218 Gordon Jun 2007 A1
20070190150 Ito et al. Aug 2007 A1
20070224253 Franklin Sep 2007 A1
20070260201 Prausnitz et al. Nov 2007 A1
20070269522 Wold Nov 2007 A1
20070293826 Wall et al. Dec 2007 A1
20080004421 Chenault Jan 2008 A1
20080009800 Nickel Jan 2008 A1
20080015494 Santini, Jr. et al. Jan 2008 A1
20080033228 Rastegar et al. Feb 2008 A1
20080039791 Abboud et al. Feb 2008 A1
20080058706 Zhang et al. Mar 2008 A1
20080063698 Hartwig Mar 2008 A1
20080091139 Srinivasan et al. Apr 2008 A1
20080110463 Hajgato et al. May 2008 A1
20080125744 Treacy May 2008 A1
20080152592 Rebec Jun 2008 A1
20080167641 Hansen et al. Jul 2008 A1
20080183144 Trautman et al. Jul 2008 A1
20080195018 Larson et al. Aug 2008 A1
20080208107 McRae et al. Aug 2008 A1
20080214987 Xu Sep 2008 A1
20080221552 Leonard Sep 2008 A1
20080234656 Pettis et al. Sep 2008 A1
20080312610 Binks et al. Dec 2008 A1
20080317615 Banister Dec 2008 A1
20090007904 Schuster et al. Jan 2009 A1
20090020521 Blaszczykiewicz et al. Jan 2009 A1
20090026069 Liao et al. Jan 2009 A1
20090041833 Bettinger et al. Feb 2009 A1
20090042970 Herschkowitz et al. Feb 2009 A1
20090048555 Stryker et al. Feb 2009 A1
20090060986 Yum et al. Mar 2009 A1
20090085444 Alvarez Icaza Rivera et al. Apr 2009 A1
20090099545 Nilsson et al. Apr 2009 A1
20090118662 Schnall May 2009 A1
20090221971 Mejlhede et al. Sep 2009 A1
20090227988 Wood, Jr. et al. Sep 2009 A1
20090232685 Kamitani et al. Sep 2009 A1
20090317442 Banister et al. Dec 2009 A1
20100004638 Gibson Jan 2010 A1
20100074953 Chaouk et al. Mar 2010 A1
20110172645 Moga et al. Jul 2011 A1
20130172180 Naumann Jul 2013 A1
20130337566 Schmidt Dec 2013 A1
20140048558 Lee Feb 2014 A1
Foreign Referenced Citations (37)
Number Date Country
2 477 181 Apr 2004 CA
1080829 Mar 2002 CN
1934776 Mar 2007 CN
199 12 606 Dec 2000 DE
0 723 982 Jul 1996 EP
0 736 556 Oct 1996 EP
0882890 Dec 1998 EP
1 454 935 Sep 2004 EP
58-25326 Feb 1983 JP
60-235847 Nov 1985 JP
02-004826 Jan 1990 JP
02 137 930 May 1990 JP
08-283540 Oct 1996 JP
09 287 571 Nov 1997 JP
2004-514770 May 2004 JP
2004-261045 Sep 2004 JP
2004-269882 Sep 2004 JP
2005269773 Sep 2005 JP
2006353034 Dec 2006 JP
2008211915 Sep 2008 JP
2009046649 Mar 2009 JP
WO 9617170 Jun 1996 WO
WO 9620971 Jul 1996 WO
WO 9742412 Nov 1997 WO
WO 0028215 May 2000 WO
WO 0244240 Jun 2002 WO
WO 2004031581 Apr 2004 WO
WO 2004076859 Sep 2004 WO
WO 2005061014 Jul 2005 WO
WO 2005118008 Dec 2005 WO
WO 2006065884 Jun 2006 WO
WO2006065884 Jun 2006 WO
WO 2006065884 Jun 2006 WO
WO 2008079440 Jul 2008 WO
WO2008129549 Oct 2008 WO
WO 2009069086 Jun 2009 WO
WO2011032011 Mar 2011 WO
Non-Patent Literature Citations (106)
Entry
PCT International Search Report and International Preliminary Report on Patentability, dated Oct. 22, 2004, PCT/US04/005922.
Yoshioka, Yuka and Calbert, Paul, “Epoxy-Based Electroactive Polymer Gels”, Experimental Mechanics, Dec. 2002, vol. 45, No. 5.
PCT International Search Report and International Preliminary Report on Patentability, dated Oct. 25, 2006, PCT/US05/45210.
PCT International Search Report and International Preliminary Report on Patentability, dated Jul. 7, 2008, PCT/US07/73188.
PCT International Search Report and International Preliminary Report on Patentability, dated Feb. 19, 2009, PCT/US08/85421.
Indian Examination Report; Indian Patent Application Serial No. 2371/CHENP/2005, dated Sep. 7, 2006.
Official Action, U.S. Appl. No. 11/721,800, dated Aug. 27, 2010.
Unsolicited letter from Dr. Elson Silva, dated Oct. 21, 2010 (5 pages).
“An Electrochemical Microactuator: Principle and First Results”, Neagu et al. Journal of Microelectromechanical Systems, vol. 5, No. 1, Mar. 1996 (7 pgs).
“ElectroActive Polymers—EAPs,” downloaded from http://www.azom.com on Dec. 16, 2013 (5 pgs).
“Epoxy-Based Electroactive Polymer Gels”, Yoshioka Y and Calvert P, Experimental Mechanics, vol. 42, No. 4, Dec. 2002, pp. 404-408 (5 pgs).
“Magnetic Driven Compression Cascade and Packaging”, IBM Technical Disclosure Bulletin, IBM Corp., col. 38, co. 1, Jan. 1995 (3 pgs).
“Micro-Dispensing Positive Displacement Pump”, Anonymous, Research Disclosure, Mason Publications, Hampshire GB, vol. 374, No. 4, Jun. 1995 (9 pgs).
“Structure and Mechanism of Two Types of Micro-Pump Using Polymer Gel”, Hattori et al., Micro Electro Mechanical Systems, 1992, MEMS 92, Proceedings. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robot, IEEE Travemunde, Germany, Feb. 1992 (6 pgs).
Bar-Cohen, Y., “Electroactive polymers (EAP) actuators as artificial muscles: reality, potential and challenges,” SPIE Press, 2001, 671 pgs, (book description only, 4 pgs).
Canadian Official Action issued in Appln. No. 2,557,325, dated Feb. 8, 2011 (5 pgs).
Chinese Notification of ReExamination and English translation, Appln. or Pat. No. 200580048306.3; dated Aug. 22, 2014 (11 pgs).
Chinese Office Action (w/English translation) issued in corresponding application No. 200780032137.3, dated Mar. 12, 2013 (14 pgs).
Chinese Office Action and Translation dated Jul. 6, 2011 issued in Chinese Patent Appln. No. 200780032137.3 (7 pgs).
Chinese Office Action issued Jul. 1, 2014 with English translation, Appln. No. or Patent No. 201180007957.3 (17 pgs).
Chinese Office Action, Application/Patent No. 200780032137.3, dated Dec. 23, 2011 (6 pgs).
Chinese Official Action + translation dated Feb. 1, 2011 issued in Appln. No. 200780032137.3, (8 pgs).
Chinese Official Action dated Mar. 17, 2011, Appln. No. 200580048306.3 (5 pgs).
Chinese Official Action issued in corresponding Chinese Patent Appln. Serial No. 200580048306.3 dated Nov. 4, 2011 (5 pgs).
European Office Action dated Sep. 14, 2010, Appln. No. 07 872 242.8 -2102, (6 pgs).
European Official Action issued in Appln. No. 04714231.0, dated May 11, 2011 (2 pgs).
European Official Action issued in Appln. No. 04714231.0-2315/1611353, dated Oct. 4, 2010 (4 pgs).
European Official Action, Apr. 6, 2011 issued in Appln. No. 07 872 242.8-2102 (4 pages).
European Official Action, Aug. 29, 2011 issued in Appln. No. 07 872 242.8-2102 (6 pages).
European Search Report dated Feb. 18, 2011 issued in corresponding Appln. No. 10014840.2-2315 (7 pgs).
European Search Report dated Jun. 8, 2009, Serial No. 07872242.8-2102 (7 pgs).
First Examination Report dated Dec. 31, 2013, Indian Patent a plication No. 3011/CHENP/2007 (2 pgs).
Indian Examination Report; Indian Patent Application Serial No. 2371/CHENP/2005, dated Sep. 7, 2006 (2 pgs).
International Preliminary Report on Patentability issued in PCT/US10/48489 dated Mar. 13, 2012 (12 pgs).
International Search Report and Written Opinion issued in corresponding PCT Patent Appln. Serial No. PCT/US2012/057129 dated Apr. 1, 2014 ( 7 pgs).
International Search Report and Written Opinion of the International Search Authority issued in PCT/US09/34557, dated Apr. 13, 2009 (6 pgs).
Japanese Office Action with translation, Patent Appln. 2009-519642, dated Jul. 9, 2012 (9 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Mar. 5, 2008 (41 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Sep. 16, 2008 (8 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Jan. 2, 2009 (9 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Jul. 1, 2009 (7 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Dec. 28, 2009 (6 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated May 5, 2010 (7 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Sep. 15, 2010 (8 pgs).
Office Action issued in related U.S. Appl. No. 10/786,718, dated Nov. 23, 2010 (10 pgs).
Office Action issued in related U.S. Appl. No. 11/254,537, dated Sep. 17, 2007 (8 pgs).
Office Action issued in related U.S. Appl. No. 11/254,537, dated Mar. 4, 2008 (8 pgs).
Office Action issued in related U.S. Appl. No. 11/254,537, dated Jul. 21, 2008 (10 pgs).
Office Action issued in related U.S. Appl. No. 11/254,537, dated Dec. 15, 2008 (8 pgs).
Office Action issued in related U.S. Appl. No. 12/373,245, dated Feb. 2, 2011 (13 pgs).
Office Action issued in related U.S. Appl. No. 12/373,245, dated Jul. 22, 2011 (11 pgs).
Office Action issued in related U.S. Appl. No. 12/373,245, dated Jun. 30, 2014 (18 pgs).
Office Action issued in related U.S. Appl. No. 12/414,536, dated Nov. 29, 2010 (8 pgs).
Office Action issued in related U.S. Appl. No. 12/978,152, dated May 23, 2011 (9 pgs).
Office Action issued in related U.S. Appl. No. 13/018,024, dated Aug. 7, 2014 (17 pgs).
Office Action issued in related U.S. Appl. No. 13/093,648, dated Aug. 29, 2013 (5 pgs).
Office Action issued in related U.S. Appl. No. 13/395,627, dated Sep. 10, 2014 (9 pgs).
Office Action issued in related U.S. Appl. No. 13/424,172, dated Jun. 27, 2012 (14 pgs).
Office Action issued in related U.S. Appl. No. 13/424,172, dated Nov. 9, 2012 (6 pgs).
Office Action issued in related U.S. Appl. No. 14/071,371, dated Aug. 21, 2014 (16 pgs).
Office Action issued in related U.S. Appl. No. 12/745,880, dated Jun. 3, 2013 (8 pgs).
Office Action issued Nov. 23, 2012 in U.S. Appl. No. 12/745,880 (26 pgs.).
Official Action received in corresponding Chinese Application No. 200480010203.3, Sep. 14, 2007 (19 pgs).
Official Action received in corresponding Chinese Application No. 200480010203.3, Nov. 14, 2008 (5 pgs).
Official Action recieved in corresponding EPO Application. No. 04 714 231.0-2315, Nov. 13, 2008 (5 pgs).
Official Action, U.S. Appl. No. 11/721,800, dated Aug. 27, 2010 (13 pgs).
PCT International Preliminary Report on Patentability, dated Aug. 26, 2005, PCT/US04/005922 (11 pgs).
PCT International Search Report and Written Opinion, dated Oct. 22, 2004, PCT/US04/005922 (17 pgs).
PCT International Search Report and International Preliminary Report on Patentability, dated Oct. 25, 2006, PCT/US05/45210 (10 pgs).
PCT International Search Report and International Preliminary Report on Patentability, dated Jul. 7, 2008, PCT/US07/73188 (8 pgs).
PCT International Search Report and International Preliminary Report on Patentability, dated Feb. 19, 2009, PCT/US08/85421 (7 pgs).
PCT International Search Report and Written Opinion dated Mar. 28, 2011 PCT/US11/23375 (10 pgs).
PCT International Preliminary Report on Patentability issued in PCT/US2013/031062, dated Sep. 16, 2014 (9 pgs).
Search Report and Written Opinion received in Applicant's corresponding European Patent Application Serial No. 05854009.7, Nov. 11, 2009 (8 pgs).
Supplemental European Search Report issued in EP04714231, dated Jan. 25, 2007 (2 pgs).
Yoshioka et al., “Electrically Driven Miniature Hydrogels as Muscle-Like Acuators”, 2001; Proceedings of SPIE vol. 4329, pp. 216-222 (7 pgs).
Office Action issued in related U.S. Appl. No. 14/071,371, dated Dec. 18, 2014 (11 pgs).
Japanese Office Action (with translation) issued in related application No. 2012-551386, dated Jan. 28, 2015 (9 pgs).
Office Action issued in related U.S. Appl. No. 13/395,627, dated Feb. 5, 2015 (7 pgs).
Chinese Board Decision, Appln. No. 200580048306.3, dated Dec. 26, 2014 (14 pgs).
Office Action issued in related U.S. Appl. No. 12/373,245, dated Feb. 9, 2015 (11 pgs).
Office Action issued in related U.S. Appl. No. 12/918,466, dated Jul. 11, 2013 (36 pgs).
India Hearing Notice in Reference of Application No. 3011/CHENP/2007, dated Feb. 5, 2015 (1 pg).
Office Action issued in U.S. Appl. No. 13/018,024, dated Feb. 24, 2015 (31 pgs).
Office Action issued in U.S. Appl. No. 13/424,172, dated Jun. 10, 2015 (25 pgs).
Office Action issued in U.S. Appl. No. 14/347,597, dated Jun. 3, 2015 (33 pgs).
Indian Office Action issued in application No. 137/CHENP/2009, dated. Mar. 17, 2015 (2 pgs).
Office Action issued in U.S. Appl. No. 12/918,466, dated Nov. 19, 2015 (25 pgs).
Extended European Search Report issued in application No. 12836396.7, dated Nov. 10, 2015 (12 pgs).
Chinese Office Action (w/translation) issued in application No. 201380022758.9, dated Dec. 14, 2015 (12 pgs).
Banister et al., “Molecular Engineering of Polymer Actuators for Biomedical and Industrial Use,” Electroactive Polymer Actuators and Devices (EAPAD) 2012, vol. 8340 (20 pgs).
Notice of Allowance issued in U.S. Appl. No. 13/395,627, dated Sep. 16, 2015 (22 pgs).
Office Action issued in U.S. Appl. No. 12/373,245, dated Sep. 9, 2015 (20 pgs).
Chinese Office Action issued in application No. 201280057499.9, dated Aug. 28, 2015 (13 pgs).
Indian Office Action issued in application No. 137/CHENP/2009, dated Oct. 29, 2015 (2 pgs).
Office Action issued in U.S. Appl. No. 12/745,880, dated Jul. 22, 2015 (23 pgs).
Chinese Office Action issued in application No. 201180007957.3, dated May 22, 2015 (11 pgs).
Office Action issued in U.S. Appl. No. 13/018,024, dated Aug. 4, 2015 (10 pgs).
Chinese Office Action issued in application No. 201180007957.3, dated Feb. 15, 2016 (12 pgs).
Chinese Office Action issued in application No. 201280057499.9, dated Jun. 28, 2016 (13 pgs).
European Office Action issued in application No. 13 760 829.5, dated Jan. 26, 2016 (4 pgs).
Notice of Allowance issued in U.S. Appl. No. 13/018,024, dated Mar. 2, 2016 (24 pgs).
Office Action issued in U.S. Appl. No. 12/373,245, dated Jun. 1, 2016 (17 pgs).
Office Action issued in U.S. Appl. No. 13/424,172, dated Feb. 24, 2016 (22 pgs).
Office Action issued in U.S. Appl. No. 14/347,597, dated Feb. 25, 2016 (32 pgs).
Office Action issued in U.S. Appl. No. 14/385,403, dated. Mar. 30, 2016 (32 pgs).
Related Publications (1)
Number Date Country
20100268200 A1 Oct 2010 US
Provisional Applications (1)
Number Date Country
60992003 Dec 2007 US